Quick Answer
BioCorRx Inc. reported Net Income Loss of -$3.44 million for the year ending 2025.
- BioCorRx Inc. showed an increase of +32.6% in Net Income Loss from 2024 to 2025.
- This data is from BioCorRx Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: -$18.8 thousand | Q2 2012: -$438.5 thousand | Q3 2012: -$161.0 thousand | Q1 2013: -$54.6 thousand | Q2 2013: -$154.9 thousand | Q3 2013: -$129.0 thousand | Q1 2014: -$1.08 million | Q2 2014: $339.6 thousand | Q3 2014: -$383.9 thousand | Q1 2015: -$203.2 thousand | Q2 2015: -$3.77 million | Q3 2015: -$697.5 thousand | Q1 2016: -$528.6 thousand | Q2 2016: -$1.07 million | Q3 2016: -$2.61 million | Q1 2017: -$38.34 million | Q2 2017: $11.30 million | Q3 2017: -$1.10 million | Q1 2018: -$1.00 million | Q2 2018: -$1.22 million | Q3 2018: -$1.89 million | Q1 2019: -$1.77 million | Q2 2019: -$2.04 million | Q3 2019: -$1.03 million | Q1 2020: -$1.08 million | Q2 2020: -$738.5 thousand | Q3 2020: -$785.2 thousand | Q1 2021: -$1.58 million | Q2 2021: -$1.06 million | Q3 2021: -$1.36 million | Q1 2022: -$945.0 thousand | Q2 2022: -$1.32 million | Q3 2022: -$951.0 thousand | Q1 2023: -$1.01 million | Q2 2023: -$923.5 thousand | Q3 2023: -$867.3 thousand | Q1 2024: -$1.24 million | Q2 2024: -$1.22 million | Q3 2024: -$1.49 million | Q1 2025: -$841.4 thousand | Q2 2025: -$1.23 million | Q3 2025: -$1.92 million.
- Over the full 16 years of available data (2010 to 2025), BioCorRx Inc.'s Net Income Loss has declined by 2,125.3%.
- Historical annual values: Fiscal year 2025: -$3.44 million | Fiscal year 2024: -$5.11 million | Fiscal year 2023: -$3.77 million | Fiscal year 2022: -$4.38 million | Fiscal year 2021: -$5.21 million | Fiscal year 2020: -$3.51 million | Fiscal year 2019: -$6.05 million | Fiscal year 2018: -$6.58 million | Fiscal year 2017: -$29.71 million | Fiscal year 2016: -$5.90 million | Fiscal year 2015: -$4.67 million | Fiscal year 2014: -$3.13 million | Fiscal year 2013: -$3.84 million | Fiscal year 2012: -$885.8 thousand | Fiscal year 2011: -$409.0 thousand | Fiscal year 2010: -$154.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: